A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral BG9928 in Patients With Heart Failure and Renal Insufficiency
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2016
At a glance
- Drugs Tonapofylline (Primary)
- Indications Heart failure
- Focus Adverse reactions
- Acronyms POSEIDON
- Sponsors Biogen
- 10 Jun 2017 Biomarkers information updated
- 22 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 17 Feb 2009 Actual initiation date (Feb 2009) added as reported by ClinicalTrials.gov.